mDR LTD 13D and 13G filings for CytoMed Therapeutics Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-24 12:01 pm Sale | 2024-12-16 | 13G | CytoMed Therapeutics Limited GDTC | mDR LTD | 1,307,933 11.330% | -28,990 (-2.17%) | Filing |
| 2024-02-14 4:00 pm Purchase | 2024-02-14 | 13G | CytoMed Therapeutics Limited GDTC | mDR LTD | 1,336,923 11.590% | 1,336,923 (New Position) | Filing |